Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
BACKGROUND AND PURPOSE: Stroke risk increases with age in patients who have nonvalvular atrial fibrillation. It is uncertain whether the efficacy of stroke prevention therapies in atrial fibrillation changes as patients age. The objective of this study was to determine the effect of age on the relat...
Κύριοι συγγραφείς: | van Walraven, C, Hart, R, Connolly, S, Austin, P, Mant, J, Hobbs, F, Koudstaal, P, Petersen, P, Perez-Gomez, F, Knottnerus, J, Boode, B, Ezekowitz, MD, Singer, D |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2009
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Stroke prevention in atrial fibrillation
ανά: Hobbs, F
Έκδοση: (2003) -
Challenges of stroke prevention in patients with atrial fibrillation in clinical practice.
ανά: Hobbs, F, κ.ά.
Έκδοση: (2011) -
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
ανά: Mant, J, κ.ά.
Έκδοση: (2007) -
Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
ανά: Taral K. Patel, κ.ά.
Έκδοση: (2012-01-01) -
Should we screen for atrial fibrillation?
ανά: Lown, M, κ.ά.
Έκδοση: (2017)